Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
about
Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.Tregs and rethinking cancer immunotherapy.Guidelines on the use of extracorporeal photopheresisEvolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndromeGamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.Cutaneous Manifestations in HTLV-I Positive Blood Donors.Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.The four types of Tregs in malignant lymphomas.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Constitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoidesReciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.Regulatory T cells in chronic lymphocytic leukemia: some progress and a bit of "tolerance" in understanding disease progression.T follicular helper cells: a potential therapeutic target in follicular lymphoma.[Update on extracorporeal photopheresis].The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.Mycosis fungoides progression could be regulated by microRNAs.
P2860
Q30650570-E0F0A9E8-5F44-4BD1-B0FE-F98963D71756Q33835381-A4B0458D-C32F-45ED-A419-CD425857D6B3Q34625147-E0375616-4F68-485A-8512-8D9EF55588CCQ34918643-7D379E68-EB58-44CA-85EB-ED072F7C2686Q35022833-D35F0A15-2488-422A-88BA-31B960D56540Q35858578-E53D256E-3F24-4D3A-8954-D2BC7F227918Q36626781-2AC758EE-3D11-4F4F-8418-97DFBCF9D06AQ36982497-9C6DB254-6792-4934-A8AD-8E83A7D44E71Q37384289-B3DFCFA4-A5D2-4658-813C-E950DA9B3C6BQ37435353-E0CC4630-A2B0-462A-B185-7EBEB5C786A2Q37698501-7149FD20-7BCB-4236-9BFD-7A46859C90A7Q37929548-319131BC-C8EF-4070-AE19-21CEE1E61102Q37966000-7E5A15F9-B593-475E-96CD-28F544F01771Q38196931-63F91DE1-40C3-4F25-B720-87677ACF34AEQ39494833-561BF3E5-E26D-4D60-AEE4-4466B0B0E82DQ40090775-E64994F4-4565-4EF1-9E7C-CC6E1BBF52FDQ41849574-BC166A31-914A-484B-A2CA-E1DF27EB8970Q41916883-EC5596E8-5272-4B96-AB01-401E265471CCQ44951228-D1250717-8B8A-4FF5-A815-16B7BBB422B2Q46248185-6C21C958-BF5C-40B9-8BB9-7546567D2683Q46511243-D5C5AB8B-92E1-4460-9BC7-01627729F4DFQ49702451-1F811329-5F50-43ED-AC45-A6A39D1A5135Q53323672-3E6561CA-3D98-471C-8AEE-7B087E046A41Q54261770-89725CE0-61D8-443A-A952-DDBDAEDE080FQ54758764-93D04944-E818-44C8-AC95-EBAD6FAD0D6CQ55407685-769D983D-F71C-4AAC-9197-9D05791DF51D
P2860
Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@en
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@nl
type
label
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@en
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@nl
prefLabel
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@en
Lack of suppressive CD4+CD25+F ...... ary cutaneous T-cell lymphoma.
@nl
P2093
P2860
P50
P356
P1476
Lack of suppressive CD4+CD25+F ...... mary cutaneous T-cell lymphoma
@en
P2093
Lisa Hendry
Machteld M Tiemessen
Sean J Whittaker
P2860
P2888
P304
P356
10.1038/SJ.JID.5700371
P407
P577
2006-06-01T00:00:00Z